Mark Loeb, Ambuj Roy, Hisham Dokainish, Antonio Dans, Lia M Palileo-Villanueva, Kamilu Karaye, Jun Zhu, Yan Liang, Fastone Goma, Albertino Damasceno, Khalid F Alhabib, Gerald Yonga, Charles Mondo, Wael Almahmeed, Arif Al Mulla, Vitheya Thanabalan, Purnima Rao-Melacini, Alex Grinvalds, Tara McCready, Shrikant I Bangdiwala, Salim Yusuf
BACKGROUND: Influenza increases the risk of cardiovascular events and deaths. We aimed to see whether influenza vaccination reduces death and vascular events in patients with heart failure. METHODS: We did a pragmatic, randomised, double-blind, placebo-controlled trial in 30 centres (mostly hospitals affliated with universities or a research institute) in ten countries in Asia, the Middle East, and Africa (7 in India, 4 in Philippines, 4 in Nigeria, 6 in China, 1 in Zambia, 2 in Mozambique, 3 in Saudi Arabia, 1 in Kenya, 1 in Uganda, and 1 in Zambia)...
December 2022: Lancet Global Health